Vioxx
Celebrex
Bextra
COX-2 Inhibitors
Crestor
Neurontin
Zyprexa
Ephedra
Strattera
Remicade
Accutane
Serzone
Serevent
Tamoxifen
Baycol
Fen Phen
Rezulin
Meridia
PPA
Propulsid
Avara
Permax
Anti-Depressants
OxyContin
Tysabri
Pemoline
 
Guidant Defibrillators
Guidant Ancure Device
Sulzer Hip Replacement
Contraceptive Devices
Breast Implants
 
Welding Rods
Asbestos
Mesothelioma
Lead Poisoning
Silica
 
Cerebral Palsy
Erb's Palsy
Birth Injury
Surgical Mistake
Cancer Misdiagnosis
Nursing Home Negligence
Hospital Negligence
 
Car Accidents
Plane Accidents
Boat Accidents
Bus Accidents
Motorcycle Acc
Brain Injury
Spinal Cord Injury
Dodge Truck and SUV Recall
 
Insurance Bad Faith
Slip and Fall
Dog Bite Injury
Inadequate Security
Recall Forum
Consumer Pro
Sexual Abuse
Product Liability
General Inquiries

Resources

Network

Peers

Crestor Information

  Crestor has been associated with the following adverse side effects, according to the Public Citizen's latest petition:


    7 patients with rhabdomyolysis
4 patients with acute kidney failure
5 additional patients with kidney damage
6 patients with bleeding or abnormal bleeding tests who were also using blood thinning drugs such as coumadin
In addition, the Public Citizen reports that the FDA has received 65 reports of rhabdomyolysis and 29 cases of acute renal failure or renal insufficiency out of 4.5 million Crestor prescriptions, which is similar to the rate associated with Baycol.

    Crestor, known generically as Rosuvastatin, was approved by the Food and Drug Administration (FDA) on August 14, 2003 for the treatment of high-cholesterol. Manufactured by AstraZeneca, Crestor reduces cholesterol levels by blocking the liver from producing bad cholesterol (LDL). Crestor became the sixth cholesterol lowering "statin" drug on the U.S. market, following drugs like Lipitor, Pravachol and Zocor.

 


    Only three months after its approval, three patients in the United States who were taking approved doses of rosuvastatin developed Crestor side effects, including kidney failure or muscle damage. As in the case with Baycol, a cholesterol-lowering medicine withdrawn from the market by Bayer due to its serious side effects in August 2002, the muscle damage, known as rhabdomyolysis deteriorates the kidneys.

    The Public Citizen filed a petition to the FDA just months after Crestor's approval in an effort to prevent Crestor from being sold due to concerns over kidney toxicity. In studies before Crestor's approval, seven people were struck by cases of rhabdomyolysis. Since the original Public Citizen petition was filed with the FDA in early March, the organization said, eleven additional cases of muscle damage, ten of them in the United States, and three additional cases of kidney problems, have been reported.

    Symptoms of rhabdomyolysis and kidney damage include: muscle pain and weakness, general fatigue, fever, nausea and vomiting, and dark and discolored urine (reddish, rose, or cola colored urine). Rhabdomyolysis causes the blood serum levels of plasma creatine kinase (ck) levels to be very high. Acute kidney failure can occur and can cause death.




Please share your opinion with us.
Your name:
Your email:
How dangerious do you think this is?:
Write a review for this product:

Copyright 2006 LawsuitResources.com
Donate Car for Free Vacation - Create A Sports Logo - Master's Commission - Street Paintings - Homes Neighborhood In California